Invesaro

Stocks STN Financial statements

Financial statements

STANTEC INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STANTEC INC files with the SEC in its annual reports.

In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue4,3004,0294,2844,8274,7304,5775,6776,4807,5008,144
Cost of revenue1,4221,4121,5401,7031,7541,6732,0402,322
Gross profit1,6761,7621,8152,0081,9311,9632,4172,745
Selling, general and administrative1,3351,4081,4381,4341,3531,4241,7431,9652,2862,458
Pre-tax income181264226266217263325408465630
Income tax50.31675571.157.662.378.191.2104151
Income from continuing operations97171194159201247317362479
Net income1319747.4194171201247317362479
EPS, basic1.170.810.401.661.461.722.132.853.174.20
EPS, diluted1.170.810.401.661.461.722.122.853.174.20

Balance sheet

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents211240185224290194148353229398
Receivables8068168788187388241,0281,0641,3241,307
Total current assets1,5831,6081,6361,5801,5651,6641,9382,2732,5492,791
Property, plant and equipment214213289287240234251268299308
Lease right-of-use assets559447477470443474545
Goodwill1,8281,5571,6211,6521,6742,1842,3462,0742,7133,222
Intangible assets450262248220182373320266427595
Total assets4,2853,8834,0104,5624,3895,2265,6535,7666,9567,957
Accounts payable7187055675765766357568421,0191,125
Total current liabilities1,0731,1568941,0069871,1791,4101,6171,9792,266
Lease liabilities589526545522478529585
Total liabilities2,3081,9842,1012,6842,4603,2243,3673,3154,0114,717
Total debt1,0217409348616811,2451,2361,0981,3841,818
Retained earnings9189478519189591,0431,155
Shareholders' equity1,9761,8961,8761,8761,9292,0021,9922,4512,9453,240
Minority interests0.831.81.60.80.50.4
Total equity1,9761,8961,8781,8771,9292,0021,9922,4512,9453,240
Total liabilities and equity4,2853,8834,0104,5624,3895,2265,6535,7666,9567,957

Cash flow statement

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1319747.4194171201247317362479
Cash from operations286264173453604397304520603863
Capital expenditures-58.3-58.9-125-56.7-31.2-45.8-68.5
Cash from investing-1,13760.3-224-135-102-765-73.8-202-605-534
Debt issued457259
Debt repaid-282-462-80.3-448
Stock issued02780
Share buybacks-18.2-14.4-74.7-41.2-80.3-50.7-65.3-10
Dividends paid-46.1-55.5-61.3-64-68-72.3-78.2-84.9-94-101
Cash from financing995-281-24-286-413277-297-109-152-140
Exchange rate effect-0.6-14.321.2-12.5-8.4-6.827.8-4.429.6-19.7
Net change in cash14428.6-54.318.880.8-98.1-38.4205-124170
Free cash flow22720547.8396573351236
Interest paid30.828.130.571.651.936.461.183.596.683.7
Income taxes paid16.939.1-21.117.6-27.772.9

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.

Profitability

MetricValueHow it is calculated
Pre-tax margin7.7%Pre-tax income / revenue.
Net margin5.9%Net income / revenue.
Operating cash flow margin10.6%Cash from operations / revenue.
Effective tax rate23.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)15.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)6.4%Net income / average total assets.
SG&A / revenue30.2%Selling, general and administrative expense / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y8.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y12.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y32.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y24.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y22.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y32.5%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y25.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y23.5%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y43.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y41.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y7.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y10.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y17.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y10.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y14.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y12.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y12.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.23xCurrent assets / current liabilities.
Quick ratio0.75x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.18x(Cash + short-term investments) / current liabilities.
Debt / equity0.56xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets22.9%Total debt / total assets.
Liabilities / assets59.3%Total liabilities / total assets.
Net debtCA$1.42BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capitalCA$524.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets48.0%(Goodwill + intangible assets) / total assets.
Tangible book value-CA$575.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.09xRevenue / average total assets.
Fixed asset turnover26.8xRevenue / average property, plant and equipment.
Receivables turnover6.19xRevenue / average receivables.
Days sales outstanding59 days365 x average receivables / revenue.

Per share

MetricValueHow it is calculated
EPS, dilutedCA$4.20Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basicCA$4.20Net income per basic share, as reported (split-adjusted).
Payout ratio21.1%Dividends paid / net income, when net income is positive.
What was STANTEC INC's revenue in fiscal 2025?

STANTEC INC reported revenue of CA$8.14B for fiscal 2025, 8.6% higher than the year before.

Was STANTEC INC profitable in fiscal 2025?

Yes. Net income was CA$479.4M, a net margin of 5.9%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to STANTEC INC